The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Basavalinga Sadasivaiah Ajaikumar & PACs
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. B.S. Ajaikumar, Promoter and Director of HealthCare Global Enterprises, sold 13,92,000 equity shares (about 1.00% of total share capital) through an open market block deal on August 20, 2025. Before the sale, his combined holding along with Persons Acting in Concert stood at 1,44,98,715 shares (10.40% of total, 10.28% of diluted capital). After the sale, the holding fell to 1,31,06,715 shares (9.40% of total, 9.29% of diluted capital). Voting-rights shares dropped from 6.84% to 5.84%, while encumbered (pledged) shares remained unchanged at 49,59,539 shares (3.56%). The filing was submitted under SEBI SAST Regulation 29(2), which is mandatory when a promoter crosses the 1% change-in-holding threshold.
Promoter selling 1% of equity through a block deal is typically seen as a mildly negative signal, as it may indicate the promoter is booking profits or rebalancing personal finances. However, the promoter and PAC group still retain a 9.40% stake, and the encumbered shares remain constant, so there is no distress signal. Shareholders may watch for follow-up block deals or further promoter trimming.